Diabetes, Obesity and Metabolism Diabetes, Obesity and Metabolism RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

3 ‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid (CMPF) prevents high fat diet‐induced insulin resistance via maintenance of hepatic lipid homeostasis
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 7, 2018 Category: Endocrinology Authors: Haneesha Mohan PhD , Sydney L. Brandt MSc , Ja Hyun Kim MSc , Frances Wong Hon. BSc , Mi Lai PhD , Kacey J. Prentice PhD , Dana Al Rijjal Hon. BSc , Lilia Magomedova PhD , Battsetseg Batchuluun PhD , Elena Burdett MSc Source Type: research

Comprehensive analysis of body composition and insulin traits associated with intra ‐pancreatic fat deposition in health and new‐onset prediabetes/diabetes after acute pancreatitis
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 6, 2018 Category: Endocrinology Authors: Ruma G. Singh , Ngoc N. Nguyen , Steve V. DeSouza , Sayali A. Pendharkar , Maxim S. Petrov Source Type: research

Comment on: Glucagon ‐like peptide‐1 receptor expression in the human eye
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 6, 2018 Category: Endocrinology Authors: Rafael Sim ó , Cristina Hernández Source Type: research

Effects of intensifying triple oral antidiabetic drug therapy by initiating insulin versus enhancing oral antidiabetic drug therapy on clinical outcomes in patients with type 2 diabetes: a nationwide population ‐based, propensity score‐matched cohort study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 6, 2018 Category: Endocrinology Authors: Shihchen Kuo RPh, PhD , Chun ‐Ting Yang MS , Jin‐Shang Wu MD , Huang‐Tz Ou PhD Source Type: research

Efficacy of Intermittent Empagliflozin Supplementation on Dietary Self ‐Management and Glycemic Control in Patients With Poorly Controlled Type 2 Diabetes: A 24‐Week Randomized Controlled Trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 6, 2018 Category: Endocrinology Authors: Fukumi Yoshikawa , Naoki Kumashiro , Fumika Shigiyama , Hiroshi Uchino , Yasuyo Ando , Hiroshi Yoshino , Masahiko Miyagi , Kayoko Ikehara , Takahisa Hirose Source Type: research

Glucagon ‐like peptide‐1 receptor‐agonists for antipsychotic‐associated cardio‐metabolic risk factors: a systematic review and individual participant data meta‐analysis
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 6, 2018 Category: Endocrinology Authors: Dan Siskind , Margaret Hahn , Christoph U. Correll , Anders Fink ‐Jensen , Anthony W. Russell , Nikolaj Bak , Brian V. Broberg , Julie Larsen , Pelle L. Ishøy , Tina Vilsbøll , Filip K. Knop , Steve Kisely Source Type: research

Endogenous glucagon ‐like peptide‐1 system response is impaired during ST‐elevation myocardial infarction in type 2 diabetes patients
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 5, 2018 Category: Endocrinology Authors: Gabby Elbaz ‐Greener MD , Olga Bloch PhD , Ilya Kumets MD , Alex Blatt MD , Micha J. Rapoport MD Source Type: research

Efficacy and safety of fixed ‐dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double‐blind, controlled, phase 3 trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 5, 2018 Category: Endocrinology Authors: Ji Cheol Bae MD , Kyung Wan Min MD , Yong Hyun Kim MD , Kyoung ‐Ah Kim MD , Eun‐Gyoung Hong MD , Cheol‐Young Park MD , Song Han MS , Bong‐Soo Cha MD Source Type: research

Long ‐term cost‐effectiveness of a Patient Empowerment Programme for type 2 diabetes mellitus in primary care
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 5, 2018 Category: Endocrinology Authors: Jinxiao Lian PhD , Sarah M. McGhee PhD , Ching So BSc , June Chau MPhil , Carlos K. H. Wong PhD , William C. W. Wong MD , Cindy L. K. Lam MD Source Type: research

Risk of heart failure in a population with type 2 diabetes versus a population without diabetes with and without coronary heart disease
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 5, 2018 Category: Endocrinology Authors: Hua ‐Fen Chen MD , Ching‐An Ho MD , Chung‐Yi Li PhD Source Type: research

Metformin is the key factor for elevated plasma GDF ‐15 levels in type 2 diabetes: a nested, case‐control study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 4, 2018 Category: Endocrinology Authors: Andrea Natali , Lorenzo Nesti , Elena Venturi , Angela C. Shore , Faisel Khan , Kim Gooding , Phillip E. Gates , Helen C Looker , Fiona Dove , Isabel Goncalves , Margaretha Persson , Jan Nilsson , Source Type: research

Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with pre ‐mixed insulin
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 4, 2018 Category: Endocrinology Authors: Miao Yu MD PhD , R. Ravi Shankar MD , Ruya Zhang MD , Ye Zhang MD PhD , Jianxin Lin MS , Edward A. O'Neill PhD , Guojuan Chen MD , Shu Liu MD PhD , Yingmei Tu MD , Samuel S. Engel MD Source Type: research

Should sodium glucose co ‐transporter 2 inhibitors be considered as first line oral therapy for people with type 2 diabetes?
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 4, 2018 Category: Endocrinology Authors: Kamlesh Khunti , Samuel Seidu , Melanie J Davies Source Type: research

Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non ‐alcoholic fatty liver disease
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 4, 2018 Category: Endocrinology Authors: Masanori Shimizu , Kunihiro Suzuki , Kanako Kato , Teruo Jojima , Toshie Iijima , Toshimitsu Murohisa , Makoto Iijima , Hidehiro Takekawa , Isao Usui , Hideyuki Hiraishi , Yoshimasa Aso Source Type: research

Glucagon ‐like peptide‐1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta‐analysis
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - September 3, 2018 Category: Endocrinology Authors: Ioannis Avgerinos MD , Thomas Karagiannis MD , Konstantinos Malandris MD , Aris Liakos MD , Maria Mainou MD , Eleni Bekiari MD , David R. Matthews MD , Apostolos Tsapas MD Source Type: research